Key result
Congenital heart diseases associated with extracardiac abnormalities were associated with a significantly higher overall mortality rate compared to isolated congenital heart diseases (48.6% vs 25.2%, OR 2.24).
Why the study?
Does the presence of extracardiac abnormalities increase fetal and neonatal mortality in patients with congenital heart diseases compared to isolated congenital heart diseases?
Cohort (n=225)
No
Does the presence of extracardiac abnormalities increase fetal and neonatal mortality in patients with congenital heart diseases compared to isolated congenital heart diseases?
Odds Ratio: 2.24 (95% CI 1.26–3.98)
Absolute Event Rate: 48.6% vs 25.2%
p-value: p=<0.01
Congenital heart diseases associated with extracardiac abnormalities carry a significantly higher risk of postnatal mortality compared to isolated congenital heart diseases.
May warrant closer monitoring in congenital heart disease with extracardiac anomalies; leaves open causal links and intervention effects in this cohort.
Congenital malformations are a known cause of intrauterine death; of them, congenital heart diseases (CHDs) are accountable for the highest fetal and neonatal mortality rates. They are strongly associated with other extracardiac malformations and an early fetal mortality. Two hundred and twenty fves cases of CHDs are presented. Of them, 155 were isolated CHDs (group A) and 70 were associated with extracardiac malformations, chromosomal disorders, or genetic syndromes (group B). The overall mortality in group B was higher than that observed in group A (p <0.01). Prenatal mortality was similar in both groups: A: 8.4% (13 out of 155); B: 15.7% (11 out of 70). Postnatal mortality was A: 16.8% (26 out of 155) (p <0.01), OR: 0.52 (95% CI: 0.16-1.7); B: 32.9% (23 out of 70) (p <0.01), OR: 0.41 (95% CI: 0.20-0.83). Heart diseases associated with extracardiac abnormalities had a higher mortality rate than isolated congenital heart diseases in the period up to 60 weeks of postmenstrual age (140 days post-term). No differences were observed between both groups of patients in terms of prenatal mortality.
No takes yet. Share an insight, caveat, or question.
Pablo Marantz (2013) conducted a cohort in Congenital heart diseases (n=225). Congenital heart diseases associated with extracardiac abnormalities vs. Isolated congenital heart diseases was evaluated on Overall mortality (prenatal and postnatal up to 60 weeks of postmenstrual age) (OR 2.24, 95% CI 1.26-3.98, p=<0.01). Congenital heart diseases associated with extracardiac abnormalities were associated with a significantly higher overall mortality rate compared to isolated congenital heart diseases (48.6% vs 25.2%, OR 2.24).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: